Actively Recruiting
EEG Abnormalities in Adult ICU Patients With High Risk of Delirium
Led by Ceribell Inc. · Updated on 2026-04-21
100
Participants Needed
1
Research Sites
76 weeks
Total Duration
On this page
Sponsors
C
Ceribell Inc.
Lead Sponsor
V
Vanderbilt University Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to assess the prevalence of EEG abnormalities on Ceribell POC EEG in adult medical, surgical, and cardiovascular ICU patients with high risk of delirium
CONDITIONS
Official Title
EEG Abnormalities in Adult ICU Patients With High Risk of Delirium
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient 18 years old or older
- Requiring admission to a medical, surgical, and/or cardiovascular ICU for an expected duration of at least 24 hours
- Receiving treatment for shock (e.g., with vasopressors, intra-aortic balloon pump, or Extracorporeal Membrane Oxygenation therapy) and/or respiratory failure (e.g., on mechanical ventilation or non-invasive positive pressure ventilation)
You will not qualify if you...
- Any structural abnormality or head condition, including devices, preventing use of the Ceribell EEG system during monitoring (e.g., craniectomy with missing bone flap where electrodes would be placed)
- Anticipated use of continuous EEG for reasons other than delirium detection during the monitoring period
- Mechanical ventilation for more than 72 hours during current hospitalization or long-term ventilator support before current hospitalization
- Expected death within 12 hours of enrollment or lack of commitment to treatment (e.g., likely withdrawal of life support within 12 hours)
- Acute or chronic neurologic deficit preventing delirium assessments
- Inability to understand English
- Bilateral deafness
- Blindness preventing delirium evaluation
- Enrollment in another study disallowing co-enrollment
- Inability to obtain informed consent
- Attending physician refusal
- Patient or surrogate refusal
- Patient unable to consent with no surrogate available
- Prisoners
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232
Actively Recruiting
Research Team
M
Michelle Hofmann, MSN
CONTACT
A
Alexandra C. Fietsam, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here